Robert Iannone, EVP, Global Head of R&D & CMO: Jazz Pharmaceuticals JAZZ Sell · Filed 25/03/12

Trade details

Type: Insider sale
Amount: $332,599.23
Shares · price: 2,403 sh · $138.41 a share
Held after: 79,621 sh
Stock: Jazz Pharmaceuticals JAZZ
Person: Robert IannoneEVP, Global Head of R&D & CMO
Trade date: 25/03/10
Filed: 25/03/12
Days to filing: 2 days

Sold 2.9% of holdings

Share of holding sold: 2.9%

Jazz Pharmaceuticals trades, last 26 weeks

What else happened in Jazz Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/08~25/04/09

Robert Iannone's recent trades

Robert IannoneEVP, Global Head of R&D & CMO
Planned sale10b5-1 planJazz Pharmaceuticals
Planned sale10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$19.2M
76,921 sh
$19.2M
Filed 08/27
Traded 08/27
Robert IannoneEVP, Global Head of R&D & CMO
Sell10b5-1 planJazz Pharmaceuticals
Sell10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$1.2M
7,159 sh
$1.2M
Filed 25/11/19
Traded 25/11/17
Robert IannoneEVP, Global Head of R&D & CMO
Planned sale10b5-1 planJazz Pharmaceuticals
Planned sale10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$1.2M
7,159 sh
$1.2M
Filed 25/11/17
Traded 25/11/17
Robert IannoneEVP, Global Head of Research a
Planned saleJazz Pharmaceuticals
Planned sale
Jazz Pharmaceuticals
JAZZ
$256.2K
1,767 sh
$256.2K
Filed 25/03/10
Traded 25/03/10
Robert IannoneEVP, Global Head of R&D & CMO
Sell10b5-1 planJazz Pharmaceuticals
Sell10b5-1 plan
Jazz Pharmaceuticals
JAZZ
$764.6K
5,532 sh
$764.6K
Filed 25/03/07
Traded 25/03/07